Literature DB >> 26813190

Validity and reliability of the Chronic Oral Mucosal Diseases Questionnaire in a UK population.

Richeal Ni Riordain1, Tim Hodgson2, Stephen Porter3,4, Stefano Fedele3,4.   

Abstract

OBJECTIVE: The objective of this study was to investigate the validity and reliability of a the Chronic Oral Mucosal Diseases Questionnaire in a UK population
METHODS: Two hundred patients with chronic oral mucosal disease (oral lichen planus, recurrent aphthous stomatitis, mucous membrane pemphigoid, pemphigus vulgaris) were enrolled in this study from the Oral Medicine Department of University College London Hospitals Trust (UCLHT) Eastman Dental Hospital. Individuals were interviewed using Oral Health Impact Profile (OHIP-14), Visual Analogue Scale (VAS) and Chronic Oral Mucosal Diseases Questionnaire (COMDQ), and the construct validity and internal reliability were examined.
RESULTS: Of the 200 study participants, 100 respondents had oral lichen planus, 42 had recurrent aphthous stomatitis and 58 had vesiculobullous conditions (mucous membrane pemphigoid or pemphigus vulgaris). With regard to construct validity, a moderate to good degree of convergent validity was found between OHIP-14 and VAS and most subscales and the total COMDQ score except the patient support subscale of COMDQ (0.21-0.37).
CONCLUSION: COMDQ is a valid and reliable patient-reported outcome measure for patients with chronic oral mucosal diseases in a UK population. It can be considered a valuable instrument in both clinical practice and in oral medicine research.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chronic oral mucosal diseases; oral medicine; quality of life; validity and reliability

Mesh:

Year:  2016        PMID: 26813190     DOI: 10.1111/jop.12425

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  9 in total

1.  Validity of Chronic Oral Mucosal Diseases Questionnaire in oral submucous fibrosis.

Authors:  Kaustubh Sansare; Ruchika Kapoor; Freny Karjodkar
Journal:  Clin Oral Investig       Date:  2018-06-08       Impact factor: 3.573

2.  Patient reported outcome and experience measures of oral disease in oral medicine.

Authors:  R Ní Ríordáin; P Wiriyakijja
Journal:  Br Dent J       Date:  2017-11-03       Impact factor: 1.626

3.  The patient acceptable symptom state in oral lichen planus: identification of cut-off threshold scores in measures of pain and quality of life.

Authors:  Paswach Wiriyakijja; Stephen Porter; Stefano Fedele; Tim Hodgson; Roddy McMillan; Martina Shephard; Richeal Ni Riordain
Journal:  Clin Oral Investig       Date:  2020-11-17       Impact factor: 3.573

4.  Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study.

Authors:  Francesco Bennardo; Francesco Liborio; Selene Barone; Alessandro Antonelli; Caterina Buffone; Leonzio Fortunato; Amerigo Giudice
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

5.  Clinical characteristics of oral lichen planus and its causal context with dental restorative materials and oral health-related quality of life.

Authors:  Linda Daume; Constance Kreis; Lauren Bohner; Susanne Jung; Johannes Kleinheinz
Journal:  BMC Oral Health       Date:  2021-05-15       Impact factor: 2.757

6.  Validity and reliability of the persian version of the chronic oral mucosal diseases questionnaire.

Authors:  Atena Shirzad; Ali Bijani; Mahsa Mehryari; Mina Motallebnejad; Saman Mohsenitavakoli
Journal:  Caspian J Intern Med       Date:  2018

7.  Oral health-related quality of life in erosive/ulcerative oral lichen planus patients.

Authors:  Zahra Saberi; Adel Tabesh; Sepideh Darvish
Journal:  Dent Res J (Isfahan)       Date:  2022-07-18

8.  Does the Clinical Form of Oral Lichen Planus (OLP) Influence the Oral Health-Related Quality of Life (OHRQoL)?

Authors:  Linda Daume; Constance Kreis; Lauren Bohner; Johannes Kleinheinz; Susanne Jung
Journal:  Int J Environ Res Public Health       Date:  2020-09-11       Impact factor: 3.390

9.  European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part I.

Authors:  H Rashid; A Lamberts; L Borradori; S Alberti-Violetti; R J Barry; M Caproni; B Carey; M Carrozzo; F Caux; G Cianchini; A Corrà; G F H Diercks; F G Dikkers; G Di Zenzo; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; A V Marzano; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; C Prost; S Rauz; B D van Rhijn; M Roth; E Schmidt; J Setterfield; G Zambruno; D Zillikens; B Horváth
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-10       Impact factor: 6.166

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.